169 related articles for article (PubMed ID: 27697098)
21. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer.
Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
Arch Gynecol Obstet; 2014 Oct; 290(4):717-23. PubMed ID: 24748337
[TBL] [Abstract][Full Text] [Related]
23. Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis.
Yalçınkaya U; Uğraş N; Özgün G; Ocakoğlu G; Deligönül A; Çetintaş SK; Bilgen MS
Bosn J Basic Med Sci; 2017 Nov; 17(4):302-308. PubMed ID: 28738014
[TBL] [Abstract][Full Text] [Related]
24. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
27. URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer.
Zhang L; Huang H; Zhang L; Hou T; Wu S; Huang Q; Song L; Liu J
BMC Cancer; 2014 Nov; 14():885. PubMed ID: 25427922
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
29. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
31. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
Li Y; Zhou HC; Zhang Y; Huang H
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
[TBL] [Abstract][Full Text] [Related]
33. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.
Yang S; Liu Y; Xia B; Deng J; Liu T; Li Q; Yang Y; Wang Y; Ning X; Zhang Y; Xiao M
Tumour Biol; 2016 Apr; 37(4):5063-74. PubMed ID: 26546434
[TBL] [Abstract][Full Text] [Related]
34. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
35. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop.
Song H; Liu Y; Jin X; Liu Y; Yang Y; Li L; Wang X; Li G
J Cell Mol Med; 2019 Sep; 23(9):6098-6111. PubMed ID: 31273925
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Krill L; Deng W; Eskander R; Mutch D; Zweizig S; Hoang B; Ioffe O; Randall L; Lankes H; Miller DS; Birrer M
Gynecol Oncol; 2020 Feb; 156(2):423-429. PubMed ID: 31843273
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.
Zhang H; Yan T; Liu Z; Wang J; Lu Y; Li D; Liang W
J Cell Biochem; 2018 Jan; 119(1):938-947. PubMed ID: 28681918
[TBL] [Abstract][Full Text] [Related]
39. TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
Ye H; Guo X
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31332036
[TBL] [Abstract][Full Text] [Related]
40. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
